{"id":3598,"date":"2026-04-22T11:21:38","date_gmt":"2026-04-22T15:21:38","guid":{"rendered":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/"},"modified":"2026-04-22T11:22:53","modified_gmt":"2026-04-22T15:22:53","slug":"research-programs","status":"publish","type":"page","link":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en","title":{"rendered":"Research Programs"},"content":{"rendered":"

[vc_row dt_row_type=”in_container”][vc_column][vc_column_text]<\/p>\n

Funded Structuring and Collaborative Activities<\/h1>\n

M\u00e9dicament Qu\u00e9bec supports structuring research activities aimed at developing sustainable platforms, tools, and infrastructure to accelerate drug development in Qu\u00e9bec. Funded collaborative academic research programs are carried out in partnership with industry to ensure they address clear needs within the ecosystem.<\/p>\n

To achieve this, MQ deploys four complementary programs:<\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row dt_row_type=”in_container”][vc_column][vc_tta_accordion][vc_tta_section title=”STRUCTURING ACTIVITIES 2022\u20132025″ tab_id=”1765572958091-26b05449-c94a”][vc_column_text]M\u00e9dicament Qu\u00e9bec has supported eight structuring activities in small molecule and biologics development.<\/p>\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Researcher<\/th>Affiliation<\/th>Title of the activity<\/th>Partners<\/th>MQ's contribution <\/th>Partners' contribution<\/th>Status<\/th>\n<\/tr>\n<\/thead>\n
Jean-Fran\u00e7ois G\u00e9linas<\/td>C3i, H\u00f4pital Maisonneuve-Rosemont<\/td>Creation of a network: Viral vector manufacturing ecosystemDetails <\/a><\/td>C3i, BioCanRx, C\u00e9gep G\u00e9rald-Godin, CRHMR, CHU Sainte-Justine, CIUSSS de l'Est de l'\u00eele-de-Montr\u00e9al, CNRC, CRSNG, Cytiva, FHMR, IRSC, Medtq+, Modulari-T, R\u00e9seau de cellules souches, UdeM, VVector Bio<\/td>$1.5M<\/td>$3.0M<\/td>Done<\/td>\n<\/tr>\n
Hanadi Sleiman et Maureen McKeague<\/td>McGill University<\/td>Nucleic acid platform for cell-specific targeting Details <\/a><\/td>Alnylam, CNRS, CRSNG, FCI, Galenvs, KorroBio, Intellia Therapeutics, IRCM, IRSC, LDI, Mitacs, McGill<\/td>$1.2M<\/td>$0.4M<\/td>Ongoing<\/td>\n<\/tr>\n
Andr\u00e9 Charette<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Synthesis of active pharmaceutical ingredients to address shortages or meet needs in the pharmaceutical sector
\nDetails <\/a><\/td>		Kemitek, Viridios, BioVectra, Universit\u00e9 de Montr\u00e9al, FRQS, PandemicStop-AI, Acceleration Consortium<\/td>$2.0M<\/td>$0.5M<\/td>Done<\/td>\n<\/tr>\n
Michel Bouvier<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Enhancing the capacity and quality of chemical libraries to support drug discovery Details<\/a><\/td>Universit\u00e9 Laval, Universit\u00e9 de Sherbrooke, Universit\u00e9 de Montr\u00e9al, McGill University<\/td>$3.2M<\/td>$0.5M<\/td>Done<\/td>\n<\/tr>\n
Eric L\u00e9cuyer<\/td>Universit\u00e9 de Montr\u00e9al \/ IRCM<\/td>The RNA Zipcode platform: an AI-guided platform for the precise delivery of RNA-based therapies
\nDetails<\/a><\/td>		Amorchem, Kodikaz, IRCM, McGill, Ivado<\/td>$1.5M<\/td>$1.2M<\/td>Done<\/td>\n<\/tr>\n
Corinne Hoesli<\/td>McGill University<\/td>Scaling up the biomanufacturing of stem cell\u2013derived therapeutic organoids Details<\/a><\/td>Cellterix Biomedical, Saint-Gobain Life Sciences, Sartorius, Morphocell, Universit\u00e9 McGill, CHU Sainte-Justine, UQAM, Universit\u00e9 de Sherbrooke, Polytechnique Montr\u00e9al, University of British Columbia, CNRC<\/td>$1.1M<\/td>$1.4M<\/td>Done<\/td>\n<\/tr>\n
Gr\u00e9goire Leclair<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Biopharmacy platform and registry of compounded medications Details<\/a><\/td>Galenova, Gent\u00e8s et Bolduc, Viridios<\/td>$1.9M<\/td>$0.3M<\/td>Done<\/td>\n<\/tr>\n
Jean-Fran\u00e7ois Lemay<\/td>CNETE, C\u00e9gep de Shawinigan<\/td>Platform for the optimization and local production of specialized, tailored proteins to accelerate drug development
\nDetails<\/a><\/td>		Universit\u00e9 Laval, Universit\u00e9 de Sherbrooke, UQTR, Universit\u00e9 de Montr\u00e9al, INRS, H\u00e9ma-Qu\u00e9bec, GuardRx, ImmunoRx<\/td>$0.3M<\/td>$0.3M<\/td>Done<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”VACCINE TECHNOLOGY INNOVATIONS” tab_id=”1765572958100-bc0a1cab-8ffa”][vc_column_text]This program aims to stimulate and support strategic, collaborative academic initiatives that strengthen Qu\u00e9bec\u2019s capabilities in vaccine technologies and address key needs within the province\u2019s vaccine ecosystem.<\/p>\n

\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Researcher<\/th>Affiliation<\/th>Title of the activity<\/th>Partners<\/th>MQ's contribution <\/th>Partners's contribution <\/th>Status<\/th>\n<\/tr>\n<\/thead>\n
Gregory De Crescenzo<\/td>Polytechnique Montr\u00e9al<\/td>Development of a novel CHO platform for the manufacturing of intranasal influenza vaccines Details<\/a><\/td>Biodextris, Inspirevax, NRC
\n<\/td>		$1.4M<\/td>$0.7M<\/td>Ongoing<\/td>\n<\/tr>\n
J\u00e9r\u00f4me Estaquier<\/td>Universit\u00e9 Laval<\/td>Preclinical tools and services to decode B- and T-cell repertoires induced by the immune response in non-human primates (NHPs)
\nDetails<\/a><\/td>		BD (now Waters)<\/td>$0.9M<\/td>$0.5M<\/td>Ongoing<\/td>\n<\/tr>\n
Bruno Gaillet<\/td>Universit\u00e9 Laval<\/td>Lipid nanoparticle platform with an active endosomal escape system for RNA vaccines Details<\/a><\/td>Feldan Therapeutics, TransBIOTech, Universit\u00e9 de Montr\u00e9al<\/td>$1.5M<\/td>$1.0M<\/td>Ongoing<\/td>\n<\/tr>\n
Denis Leclerc<\/td>Universit\u00e9 Laval<\/td>VaxSynergy \u2013 Unlocking innovation in vaccine development through a collaborative ecosystem
\nDetails<\/a><\/td>		Glycovax Pharma, PROTEO, Fondation CHUQ, Fondation Courtois, UQAM, CNETE<\/td>$1.5M<\/td>$0.8M<\/td>Ongoing<\/td>\n<\/tr>\n
Ciriaco Piccirillo<\/td>RI-MUHC<\/td>Creation of a Quebec human immunology network to support the provincial vaccine ecosystemDetails<\/a><\/td>CellCarta, Aramis Biotechnologies, Universit\u00e9 de Montr\u00e9al<\/td>$1.5M<\/td>$1.2M<\/td>Ongoing<\/td>\n<\/tr>\n
Maryam Tabrizian<\/td>McGill University<\/td>Establishment of a platform to advance innovation in therapeutic cancer vaccines based on immunomodulatory lipid-derived nanoparticles of bacterial origin
\nD\u00e9tails<\/a><\/td>		Nanofacile, RNA T&T, Beeta Biomed, Universit\u00e9 de Montr\u00e9al, Polytechnique Montr\u00e9al<\/td>$0.7M<\/td>$0.4M<\/td>Ongoing<\/td>\n<\/tr>\n
<\/td><\/td><\/td><\/td><\/td><\/td><\/td>\n<\/tr>\n
<\/td><\/td><\/td><\/td><\/td><\/td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”TRANSLATIONAL ACTIVITIES” tab_id=”1765573014376-4225d7b8-5f77″][vc_column_text]<\/p>\n

M\u00e9dicament Qu\u00e9bec has established a process to reinvest in select Phase 1 activities in order to support their progression, long-term sustainability, and self-sufficiency. Three commercially promising initiatives were supported, with the objective of translating initial outcomes into tangible products or services and actively promoting them within the ecosystem.<\/p>\n

Activity leads were supported by the M\u00e9dicament Qu\u00e9bec coordination team throughout the preparation of their proposals and presentations.<\/p>\n

\n\n\n\n\t\n\n\t\n\t\n\t
Researcher<\/th>Affiliation<\/th>Title of the activit\u00e9<\/th>MQ\u2019s contribution<\/th>Partners' contribution<\/th>Status<\/th>\n<\/tr>\n<\/thead>\n
Andr\u00e9 Charette<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Amnis<\/td>$175,000<\/td>$117,800<\/td>Done<\/td>\n<\/tr>\n
Gr\u00e9goire Leclair<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Standardized Compounding in Quebec: from a M\u00e9dicament Qu\u00e9bec project to a sustainable organization<\/td>$175,000<\/td>$127,000<\/td>Done<\/td>\n<\/tr>\n
Jean-Fran\u00e7ois Lemay<\/td>CNETE, C\u00e9gep de Shawinigan<\/td>Prot\u00e9ines Qu\u00e9bec: protein customization and production services<\/td>$175,000<\/td>$130,000<\/td>Done<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”LA CELLULE \/ AReNA” tab_id=”1765573035652-12f3a7f4-f275″][vc_column_text]This program aims to support the development of innovative technologies for the RNA therapeutics sector, accelerate the commercialization of Qu\u00e9bec-based biopharmaceutical innovations, and strengthen the competitiveness of our companies both locally and internationally.<\/p>\n

\n\n\n\n\t\n\n\t\n\t\n\t
Researcher<\/th>Affiliation<\/th>Title of the activity<\/th>Partners<\/th>MQ's contribution<\/th>Partners' contribution<\/th>Status<\/th>\n<\/tr>\n<\/thead>\n
Xavier Banquy<\/td>Universit\u00e9 de Montr\u00e9al<\/td>Improving yields and scalability of RNA-based therapies through novel intensified manufacturing methods \u2013 Phase 1
\nDetails<\/a><\/td>		RNA T&T, Lipoid, Flowid, Polytechnique Montr\u00e9al<\/td>$1.2M<\/td>$0.6M<\/td>Ongoing<\/td>\n<\/tr>\n
J\u00f6rg Hermann Fritz<\/td>McGill University<\/td>Integrated platform for rapid antigen identification, delivery, and evaluation of mRNA vaccines
\nDetails<\/a><\/td>		Universit\u00e9 McGill, MHL Consultation Technique et Recherche Inc, NovoArc GmbH<\/td>$1.2M<\/td>$1.0M<\/td>Ongoing<\/td>\n<\/tr>\n
Beno\u00eet Chabot<\/td>Universit\u00e9 de Sherbrooke<\/td>Mobilization of platforms within Quebec\u2019s RNA Therapeutics Development and Manufacturing Network
\nDetails to come<\/td>		Galenvs Sciences, NemRod, NumBio Therapeutics, Element Biosciences, Oxford Nanopore, Technologies, New England Biolabs, McGill, IRCM, IR-CUSM, D2R, Fondation des Leucodystrophie
\n<\/td>		$1.3M<\/td><\/td>Ongoing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_column_text]* Partner contributions are final for completed activities. The total amount may be higher for ongoing activities.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row dt_row_type=”in_container”][vc_column][vc_column_text] Funded Structuring and Collaborative Activities M\u00e9dicament Qu\u00e9bec supports structuring research activities aimed at developing sustainable platforms, tools, and infrastructure to accelerate drug development…<\/p>\n

Lire la suite<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"parent":551,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-homepage.php","meta":{"footnotes":""},"class_list":["post-3598","page","type-page","status-publish","hentry"],"yoast_head":"\nResearch Programs - M\u00e9dicament Qu\u00e9bec<\/title>\n<meta name=\"description\" content=\"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Research Programs - M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"og:description\" content=\"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en\" \/>\n<meta property=\"og:site_name\" content=\"M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-22T15:22:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/home\\\/research-programs\\\/?lang=en\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/home\\\/research-programs\\\/?lang=en\",\"name\":\"Research Programs - M\u00e9dicament Qu\u00e9bec\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\"},\"datePublished\":\"2026-04-22T15:21:38+00:00\",\"dateModified\":\"2026-04-22T15:22:53+00:00\",\"description\":\"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/home\\\/research-programs\\\/?lang=en#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/home\\\/research-programs\\\/?lang=en\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/home\\\/research-programs\\\/?lang=en#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/medicamentquebec.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medicamentquebec.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research Programs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicamentquebec.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"width\":494,\"height\":266,\"caption\":\"M\u00e9dicament Qu\u00e9bec\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Research Programs - M\u00e9dicament Qu\u00e9bec","description":"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/","og_locale":"fr_FR","og_type":"article","og_title":"Research Programs - M\u00e9dicament Qu\u00e9bec","og_description":"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.","og_url":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en","og_site_name":"M\u00e9dicament Qu\u00e9bec","article_modified_time":"2026-04-22T15:22:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en","url":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en","name":"Research Programs - M\u00e9dicament Qu\u00e9bec","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/#website"},"datePublished":"2026-04-22T15:21:38+00:00","dateModified":"2026-04-22T15:22:53+00:00","description":"En favorisant les partenariats entre les universit\u00e9s, les coll\u00e8ges et des entreprises pharmaceutiques, M\u00e9dicament Qu\u00e9bec acc\u00e9l\u00e8re la d\u00e9couverte et la production du m\u00e9dicament et l\u2019innovation en sant\u00e9.","breadcrumb":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicamentquebec.ca\/index.php\/home\/research-programs\/?lang=en#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/medicamentquebec.ca\/"},{"@type":"ListItem","position":2,"name":"Home","item":"https:\/\/medicamentquebec.ca\/"},{"@type":"ListItem","position":3,"name":"Research Programs"}]},{"@type":"WebSite","@id":"https:\/\/medicamentquebec.ca\/#website","url":"https:\/\/medicamentquebec.ca\/","name":"M\u00e9dicament Qu\u00e9bec","description":"","publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicamentquebec.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/medicamentquebec.ca\/#organization","name":"M\u00e9dicament Qu\u00e9bec","url":"https:\/\/medicamentquebec.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","width":494,"height":266,"caption":"M\u00e9dicament Qu\u00e9bec"},"image":{"@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/pages\/3598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/comments?post=3598"}],"version-history":[{"count":7,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/pages\/3598\/revisions"}],"predecessor-version":[{"id":3605,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/pages\/3598\/revisions\/3605"}],"up":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/pages\/551"}],"wp:attachment":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media?parent=3598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}